IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 10.75
0.00 (0.00%)
At close: Dec 5, 2025
IXICO Market Cap
IXICO has a market cap or net worth of 9.96 million as of December 5, 2025. Its market cap has decreased by -15.69% in one year.
Market Cap
9.96M
Enterprise Value
5.23M
Revenue
6.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.75
Market Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 9.96M, an increase of 12.92%. That is a compound annual growth rate of 1.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 9.96M | -8.51% |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | 48.27M | 13.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.00B |
| GSK plc | 73.57B |
| Haleon | 32.16B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |